Spicer L J, Stewart R E, Alvarez P, Francisco C C, Keefer B E
Department of Animal Science, Oklahoma State University, Stillwater 74078, USA.
Biol Reprod. 1997 Jun;56(6):1458-65. doi: 10.1095/biolreprod56.6.1458.
This study was aimed at testing the hypothesis that the insulin-like growth factor-binding proteins (IGFBP)-2 and -3 can modulate the hormone-dependent differentiation of thecal cells in vitro. Thecal cells from large (> or = 8 mm) follicles were collected from cattle, cultured for 2 days in medium containing 10% fetal calf serum, washed, and then treated for an additional 2 days in serum-free medium with bovine LH (100 ng/ml), recombinant human insulin-like growth factor (IGF)-I (0 or 30 ng/ml), recombinant human IGFBP-2 (0, 200, or 400 ng/ml; i.e., 0, 6.5, or 12.9 nM), or recombinant human IGFBP-3 (0, 200, or 400 ng/ml; i.e., 0, 4.3, or 8.5 nM). IGFBP-2 (200 and 400 ng/ml) inhibited (p < 0.05) IGF-I-induced androstenedione production by 18-30% but did not influence (p > 0.10) progesterone production or thecal cell proliferation in the presence of LH and/or IGF-I. In contrast, IGFBP-3 (200 ng/ml) inhibited the IGF-I-induced increase in thecal cell numbers by 76%, and thecal cell progesterone and androstenedione production by 52% and 89%, respectively. A higher dose of IGF-I (i.e., 100 ng/ml) overcame the inhibitory effects of IGFBP-3 on IGF-I-induced cell proliferation and on progesterone and androstenedione production by thecal cells. As with IGFBP-2, IGFBP-3 had no effect (p > 0.10) on LH-induced progesterone or androstenedione production by thecal cells in the absence of IGF-I. Both IGFBP-2 and IGFBP-3 directly inhibited [125I]IGF-I and -II binding to thecal cells; IGFBP-2 was a weaker inhibitor of thecal [125I]IGF-I and -II binding than IGFBP-3. These results indicate that IGFBP-3 has a more pronounced inhibitory effect than IGFBP-2 on IGF-I action in cultured bovine thecal cells. Thus, IGFBP-3 may play a more significant role than IGFBP-2 in regulating thecal cell proliferation and steroidogenesis during follicular development in cattle.
胰岛素样生长因子结合蛋白(IGFBP)-2和-3可在体外调节卵泡膜细胞的激素依赖性分化。从牛体内采集直径大于或等于8毫米的大卵泡中的卵泡膜细胞,在含10%胎牛血清的培养基中培养2天,洗涤后,再在无血清培养基中用牛促黄体素(LH,100纳克/毫升)、重组人胰岛素样生长因子(IGF)-I(0或30纳克/毫升)、重组人IGFBP-2(0、200或400纳克/毫升,即0、6.5或12.9纳摩尔)或重组人IGFBP-3(0、200或400纳克/毫升,即0、4.3或8.5纳摩尔)处理2天。IGFBP-2(200和400纳克/毫升)可抑制(p<0.05)IGF-I诱导的雄烯二酮生成,抑制率为18%至30%,但在LH和/或IGF-I存在的情况下,对孕酮生成或卵泡膜细胞增殖无影响(p>0.10)。相比之下,IGFBP-3(200纳克/毫升)可使IGF-I诱导的卵泡膜细胞数量增加减少76%,使卵泡膜细胞孕酮和雄烯二酮生成分别减少52%和89%。更高剂量的IGF-I(即100纳克/毫升)可克服IGFBP-3对IGF-I诱导的细胞增殖以及卵泡膜细胞孕酮和雄烯二酮生成的抑制作用。与IGFBP-2一样,在无IGF-I的情况下,IGFBP-3对LH诱导的卵泡膜细胞孕酮或雄烯二酮生成无影响(p>0.10)。IGFBP-2和IGFBP-3均可直接抑制[125I]IGF-I和-II与卵泡膜细胞的结合;IGFBP-2对卵泡膜细胞[125I]IGF-I和-II结合的抑制作用弱于IGFBP-3。这些结果表明,在培养的牛卵泡膜细胞中,IGFBP-3对IGF-I作用的抑制作用比IGFBP-2更显著。因此,在调节牛卵泡发育过程中的卵泡膜细胞增殖和类固醇生成方面,IGFBP-3可能比IGFBP-2发挥更重要的作用。